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Abstract 1 
Objective 2 
Bypass surgery is a special technique used to treat complex ICA aneurysms. The aim of this 3 
retrospective study is to provide a comprehensive description of treatment and outcome of 4 
complex ICA aneurysms at different ICA segments (cavernous, supraclinoid, ICA 5 
bifurcation) treated with bypass procedures. 6 
Methods 7 
We identified 39 consecutive patients with 41 complex ICA aneurysms that were treated 8 
with 44 bypass procedures between 1998 and 2016. We divided the aneurysms into three 9 
anatomic subgroups to review our treatment strategy. All the imaging studies and medical 10 
records were reviewed for relevant information. 11 
Results 12 
The aneurysm occlusion (n=34, 83%) or flow modification (n=5, 12%) was achieved in 39 13 
aneurysms (95%). The long-term bypass patency rate was 68% (n=30). Minor 14 
postoperative ischaemia or hemorrhage was commonly seen (n=20, 51%), but large-scale 15 
strokes were rare (n=1, 3%). Preoperative dysfunction of extraocular muscles (CN III, IV 16 
and VI) showed low to moderate improvement rates (20-50%). Preoperative vision 17 
disturbance (CN II) improved seldom (22%). At the latest follow-up (mean; 51 months) 29 18 
patients (74%) were independent (mRS ≤2). 19 
Conclusions 20 
Bypass surgery for complex ICA aneurysms is a feasible treatment method with an 21 
acceptable risk profile. Patients should be informed of the uncertainty related to 22 
improvement of pre-treatment cranial nerve dysfunctions. 23 
Key Words 24 
Complex aneurysm, Intracranial aneurysm, Bypass, ELANA, Cranial nerve dysfunction 25 
 26 
Introduction 27 
Complex ICA aneurysms are a heterogenous group of challenging lesions, but as the 28 
classification has remained subjective, the incidence of these lesions is not exactly 29 
known.1,2 It is estimated that complex ICA aneurysms represent less than 1% of all 30 
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intracranial aneurysms. Many of these aneurysms are giant (≥25 mm) in size,3,4 or fusiform 31 
in nature. The typical presenting symptoms of these lesions are cranial nerve dysfunctions 32 
(CND) or thromboembolic symptoms.5–8 33 
 34 
The treatment of complex ICA aneurysms has to be tailored on case-by-case basis. Direct 35 
obliteration is seldom possible. More complex solutions such as proximal occlusion or 36 
trapping and the use of cerebrovascular bypasses are often necessary. Only in the recent 37 
years have flow diverters emerged as an endovascular treatment option for these lesions. 38 
Despite the technical development in the endovascular field, cerebrovascular bypass 39 
procedures still remain an important technique for treating some of the complex 40 
aneurysms.9,10 Bypasses combined with arterial occlusions can also serve as salvage option 41 
when all other treatment modalities have failed.10,11 42 
 43 
The series published on complex ICA aneurysms treated with bypasses are usually small 44 
and focus mainly on technical nuances, but a more general analysis of the treatment 45 
strategy is often lacking.6,8,20,12–19 We present a single-center series of 39 consecutive 46 
patients with 41 complex or giant ICA aneurysms treated with 44 bypass procedures during 47 
1998 - 2016. The aim of this study is to analyze bypass treatment and outcome for the ICA 48 
aneurysms at three separate anatomical segments (cavernous ICA, supraclinoid ICA and 49 
ICA bifurcation). In addition to aneurysm obliteration rate, the outcome analysis focuses on 50 
occurrence of ischaemic or hemorrhagic lesions and improvement of CNDs. 51 
 52 
Methods 53 
Patients and aneurysms 54 
Data were retrieved from the Helsinki Bypass database, which includes all the patients 55 
treated with bypass procedures at the Department of Neurosurgery at Helsinki University 56 
Hospital (HUS) after 1998. We identified 39 consecutive patients with 41 complex ICA 57 
aneurysms treated with 44 bypass procedures between 1998 and 2016. 58 
 59 
We divided the ICA aneurysms into three groups for the analysis: (i) cavernous segment 60 
ICA (ICAcav), (ii) supraclinoid and pre-bifurcation ICA (ICAsup), and (iii) ICA 61 
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bifurcation (ICAbif). Treatment strategies and bypass options for each of these three 62 
segments differ due to the restrains given by the vascular anatomy.  63 
 64 
Radiological data 65 
Digital radiological images were recalled from the hospital’s central digital archiving 66 
system (PACS; Agfa, Impax), launched in 1998. Imaging data were available for all the 67 
patients. Multiple imaging modalities were used in overlapping combinations. All patients 68 
had the preoperative digital subtraction angiography (DSA) study. Balloon test occlusion 69 
(BTO) was used to assess the arterial collateral blood flow in 25 (64%) cases. Altogether 26 70 
patients (67%) had a preoperative computed tomography angiography (CTA) scan and 35 71 
patients (90%) had a magnetic resonance imaging (MRI) scan. Additional CT perfusion or 72 
MRI perfusion studies were done in eight cases (21%). In all of the 41 aneurysms, the 73 
different imaging combinations ultimately led to a conclusion that a bypass procedure was 74 
indicated to treat the aneurysms. 75 
 76 
Radiological assessment 77 
The ICA aneurysms and their respective segments were identified from the radiological 78 
studies. Saccular aneurysms were measured for their largest diameter and fusiform 79 
aneurysms for the length of the affected artery segment. Arteries branching from the 80 
aneurysm wall, intraluminal thrombosis and wall calcifications were noted. The treatment 81 
strategy, its execution, patency of the bypass and aneurysm occlusion were reviewed from 82 
the patient records and the imaging studies. 83 
 84 
Patient characteristics 85 
During the 19 years, 39 patients with 41 ICA aneurysms were treated with 44 bypass 86 
procedures including three redo surgeries. Most patients were Finnish (n = 35, 90%) and 21 87 
patients (54%) were female. The mean patient age at the time of surgery was 50 years. The 88 
baseline characteristics of the study population are presented in Table 1. 89 
 90 
A majority of the patients were preoperatively independent (modified Rankin Scale 91 
[mRS] score ≤2; n=31, 79%). Two-thirds of the patients (n=26; 67%) had symptoms of 92 
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mass effect as the main presenting symptom (i.e. cranial nerve dysfunction [CND]). About 93 
two-thirds of the aneurysms were giant (>25 mm) in size (n=26, 63%). Two patients had 94 
bilateral ICA aneurysms. Ten patients (26%) had previous history of treatment for their 95 
ICA aneurysm. 96 
 97 
Use of bypass in aneurysms 98 
Between 1998-2016, a total of 255 intracranial bypass operations were performed at our 99 
department. Almost half of these surgeries (n=124, 49%) were done for aneurysms. 100 
Complex ICA aneurysms represented 16% of the total case volume (n=41). The bypass 101 
technique evolved over the study period, which also affected our treatment decisions. Of 102 
the 255 bypasses, 224 (88%) were done using conventional techniques and 31 (12%) with 103 
the Excimer Laser-Assisted Non-occlusive Anastomosis (ELANA) technique. The ELANA 104 
technique was used during the years 2003-2010. The main reason for abandoning the 105 
ELANA technique later on was its complexity and unpredictability, while at the same time 106 
we had become more proficient and technically capable with the conventional bypasses. 107 
The graft and recipient selection in ICA bypass surgeries varied based on the technique 108 
used. 109 
 110 
Outcome 111 
The patency of the bypass and the obliteration of the target aneurysm were evaluated from 112 
the postoperative images. We were also interested in the postoperative ischaemic and 113 
hemorrhagic complications and later improvement of CNDs. The outcome was defined 114 
using the modified Rankin Scale (mRS) as good (≤2) and as poor (3-5); scores were 115 
assessed at discharge and at the latest follow-up visit. 116 
 117 
Statistical methods 118 
 119 
Commercial statistical software (IBM SPSS Statistics, version 25.0.0) was used to manage 120 
the data. The tools used were for descriptive and statistical analysis. 121 
 122 
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The Helsinki Cerebral Bypass database has the approval of the Ethics Committee of the 123 
Helsinki University Hospital (HUS).  124 
 125 
Results 126 
Treatment 127 
Cavernous ICA aneurysms 128 
There were 22 patients with 23 cavernous ICA (ICAcav) aneurysms including one patient 129 
with bilateral mirror aneurysms [Figure 1; Figure 2A]. Pre-treatment CNDs were seen in 130 
20 patients (86%). One aneurysm was considered as acutely ruptured [epistaxes; no. 8]. The 131 
mean aneurysm size was 26 mm (range 12-37 mm). Characteristics of these cases are 132 
presented in Table 2. 133 
 134 
The 22 patients underwent 25 bypass procedures (one bilateral case, two redo surgeries). 135 
The most frequent aneurysm treatment strategy was an EC-IC bypass followed by 136 
peroperative, proximal parent artery occlusion (PAO; n=20, 87%). Of the 23 aneurysms, 14 137 
(61%) were treated with the ELANA technique. 138 
 139 
During the early postoperative period (≤7 days), eight patients (36%) developed radiologic 140 
ischaemic lesions in varying combinations. Six of them (27%) were symptomatic. Small 141 
contusions due to retraction or manipulation around the anastomosis were seen in five cases 142 
(23%). On angiography, early bypass occlusion was detected in eight cases (32%; one redo) 143 
of which six cases were concurrent with ischaemic lesions. Only one bypass occlusion led 144 
to an extensive hemispheric infarct and resulted in a fatality [no. 18].  145 
 146 
The latest angiography showed a total occlusion of 21 aneurysms (91%). Late occlusion of 147 
the bypass was seen in four patients (18%) without complications. 148 
 149 
Supraclinoid ICA aneurysms 150 
Supraclinoid ICA (ICAsup) aneurysm was treated in 12 patients. Of the branching arteries, 151 
the Pcom most frequently originated from the aneurysm dome (n=5) [Figure 1; Figure 152 
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2B]. Two-thirds of these patients (n=8, 66%) presented with CNDs. The mean aneurysm 153 
size was 26 mm (range 2-79 mm). Characteristics of these cases are presented in Table 3. 154 
 155 
The 12 patients underwent 13 bypass procedures (one redo surgery). The most frequent 156 
aneurysm treatment strategy was an EC-IC bypass followed by peroperative proximal PAO 157 
(n=7, 58%). In two cases the aneurysm had been previously treated elsewhere only with 158 
proximal ICA occlusion, and the remaining retrograde filling through the Pcom was then 159 
occluded by endovascular means [no. 23 and 26]. In one case, the bypass served only as a 160 
protective bypass during the successful direct clipping of the aneurysm [no. 31]. Of the 12 161 
aneurysms, only two (17%) were treated with the ELANA technique. 162 
 163 
During the early postoperative period (≤7 days), half of the patients (n=6) developed new 164 
radiologic ischaemic lesions, of which four (33%) were symptomatic. Small contusions due 165 
to manipulation were seen in two cases (17%). On angiography, all but one intraoperatively 166 
occluded bypass were patent (92%). 167 
 168 
The latest angiography showed total obliteration of ten aneurysms (83%). One foreign 169 
patient had follow-up elsewhere [no. 25]. The bypass had silently occluded in one case at 170 
the latest follow-up with no clinical consequences [no. 32]. 171 
 172 
ICA-bifurcation aneurysms 173 
There were five patients with six ICA aneurysms affecting the ICA bifurcation (ICAbif) 174 
region including one patient with bilateral mirror aneurysms. In all of these aneurysms, the 175 
proximal M1 and A1 branches originated from the aneurysm dome [Figure 1; Figure 2C]. 176 
Aneurysm mass effect caused CNDs in three cases (60%). All of the aneurysms were giant 177 
(≥25 mm) with the mean diameter of 40 mm (range 25-70 mm). Characteristics of these 178 
cases are presented in Table 4. 179 
 180 
The five patients underwent six bypass procedures (one bilateral case). The conventional 181 
EC-IC bypasses were followed by various strategies to treat the aneurysm (trapping, n=2; 182 
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clip reconstruction, n=1; proximal occlusion, n=1; Crutchfield apparatuses for bilateral 183 
aneurysms). 184 
 185 
During the early postoperative period (≤7 days), three patients (50%) developed 186 
symptomatic perforator ischaemia. Additionally, in one of these three cases, the proximal 187 
ICA balloon occlusion induced thrombosis of the Pcom proximal to the aneurysm, and 188 
subsequent ischaemia mainly in the posterior cerebral artery (PCA) region [no. 38]. None 189 
of the patients had manipulation-related contusions. All the bypasses were patent on 190 
angiograms. 191 
 192 
At the latest follow-up, the treated aneurysm was occluded in three cases (50%). Small 193 
remaining aneurysmatic pouches were seen in the case of remodeled aneurysm [no. 35]. In 194 
the case of bilateral aneurysms, one Crutchfield apparatus was left partly open as a 195 
protective measure [no. 39]. The long-term bypass status remained the same. 196 
 197 
Ischaemic complications 198 
New postoperative radiologic ischaemic lesions were seen in 17 patients (43%), of which 199 
13 patients (33%) were symptomatic. The frequencies of these complications were higher 200 
in the intradural subgroups (ICAcav [n=8, 36%]; ICAsup [n=6, 50%]; ICAbif [n=3, 50%]). 201 
The ratio of perforator and main trunk ischaemia varied according to aneurysm location 202 
(ICAcav, 3:6; ICAsup, 3:4; ICAbif, 3:1). The most common specific location for ischaemic 203 
lesions was the capsular region (n=8). Only six cases (15%) had concurrently deep and 204 
superficial ischaemia, and three cases (8%) had concurrent contusions. 205 
 206 
The bypass was thrombosed in most of the ICAcav aneurysm cases with postoperative 207 
ischaemia (n=6, 75%). However, in most of these patients (n=5) the ischaemic lesions were 208 
limited. There was only one patient with full hemispheric infarct. Unlike in the ICAcav 209 
cases, the bypass was patent in all of the ICAsup and ICAbif patients with postoperative 210 
ischaemic findings. 211 
 212 
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Antiplatelet medication (acetylsalicylic acid [ASA]; 100 mg daily) was used in 36 patients 213 
(92%) postoperatively. All of the patients with new ischaemic complications were on 214 
antiplatelet therapy, and postoperative low-molecular-weight heparin (LMWH) was used in 215 
combination with ASA in eight cases (47%). This combined medication was used also in 216 
four of the occluded ICAcav bypass cases (50%). 217 
 218 
Hemorrhagic complications 219 
Post-operative extra-axial hemorrhage requiring surgical removal was seen in three cases 220 
(7%); epidural (n=2) or subdural (n=1). All three patients had different regimes for 221 
perioperative use of antithrombotics [no. 15, 18 and 27]. Manipulation-, or retraction-222 
related contusions were seen in seven patients (18%). The contusions alone caused the 223 
postoperative symptoms in two cases, concurrently with ischaemia in three cases, and two 224 
other cases had only radiologic findings. All the contusions were associated with deeper 225 
anastomosis sites, and often with the ELANA technique (n=6, 86%). Peroperative heparin 226 
use had some overrepresentation in cases with contusions (n=4, 57%) when compared to 227 
the other cases of the series (n=6, 18%). There were no intraparenchymal or subarachnoid 228 
hemorrhages requiring intervention. 229 
 230 
Cranial nerve dysfunctions 231 
A total of 29 patients (74%) had dysfunction of at least one cranial nerve as a presenting 232 
symptom. Most common was the CN VI dysfunction (n=15, 38%). Combined preoperative 233 
CNDs were associated only with the ICAcav aneurysms (n=6, 15%). Additionally, nine 234 
patients (23%; two cases preoperatively asymptomatic) developed a new postoperative 235 
CND, which was most frequently CN III weakness (n=6, 67%). During follow-up, eight 236 
patients (26 %; including two cases of only postoperative CND) had full and seven patients 237 
(23%) had partial improvement of their CNDs. More specifically, CN IV-VI functions 238 
improved most frequently among the presenting symptoms (correspondingly 1/2, 2/5 and 239 
6/15; 40-50%) and CN III function among the complications (5/6; 83%). On the other hand, 240 
preoperative visual disturbance (CN II) or CN III dysfunction showed improvement only 241 
infrequently (correspondingly 2/9 and 2/10; 22-25%). Strabismus surgery corrected two 242 
additional cases of CN VI weakness (13%). 243 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
   Nurminen  9
 244 
Clinical outcome 245 
The mean follow-up time was 51 months (median 29; range 0 – 201; 0 being for three 246 
foreign patients and for two cases of death [one case fatality; one death was intoxication not 247 
related to aneurysm disease or treatment]). At discharge, 17 patients (44%) had worse mRS 248 
score than preoperatively, and of these, 11 patients (28%) dropped from good (≤2) to poor 249 
(≥3) mRS score group. However, between discharge and the latest follow-up, 20 patients 250 
(51%) improved on the mRS scale while the scores of 9 patients (23%) rose from poor to 251 
good mRS score group mostly balancing the initial drop [Figure 3]. Of the patients with 252 
poor preoperative score (n=8, 21%), only two patients (5%) recovered into good score 253 
group. The mRS score distribution at the latest follow-up was as follows; ≤2 (n=29, 74%), 254 
3-5 (n=9, 23%), and 6 (n=1, 3% case fatality rate). Expectedly, all four patients (10%) who 255 
deteriorated permanently into the poor mRS score group were cases with postoperative 256 
ischaemic lesions or contusions. The case scores of different subgroups on modified 257 
Ranking Scale (mRS) are presented in Table 5. 258 
 259 
Discussion 260 
Bypass procedures are an acknowledged strategy to treat complex intracranial 261 
aneurysms.9,21,22 Fewer studies have focused only on complex ICA aneurysms.8,12,13,16,20,23 262 
It is difficult to obtain large series of complex ICA aneurysms due to their rarity and 263 
heterogenous nature. In our series, emphasis was on different segmental subgroups 264 
(ICAcav; ICAsup; ICAbif) and their relation to treatment strategy. 265 
 266 
Aneurysm occlusion strategy 267 
Aneurysm occlusion rates of 91-100% have been reported previously for complex ICA 268 
aneurysms treated with bypass procedures, but variable patient selection or study focus 269 
(specific treatment method, combination of aneurysm locations, or the symptoms and 270 
related improvement) makes comparison between the series difficult.6,8,9,13,20,21 In our 271 
series, the latest angiography showed that 83% of aneurysms were occluded (one case was 272 
lost to follow-up elsewhere). However, the goal of flow reversal or flow modification was 273 
achieved in 95%.  274 
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 275 
For ICAcav aneurysms the obliteration strategy with PAO alone is straightforward as no 276 
major outflow branches or terminal arteries originate from this segment. Aneurysm 277 
occlusion rates of up to 100% have been reported for endovascular PAO without any 278 
revascularization.24,25 In our series, ICAcav aneurysm occlusion rate of 91% (n=21) was 279 
ultimately achieved. We did the PAO immediately after intraoperative confirmation of the 280 
bypass patency, and often chose endovascular PAO if the STA was used as donor artery. 281 
 282 
For ICAsup aneurysms, there is more uncertainty in achieving aneurysm occlusion with 283 
simple proximal PAO as the branching arteries (OphtA, Pcom) may retrogradely fill the 284 
aneurysm, or even one another [Figure 1]. We generally choose to keep these branching 285 
arteries intact to avoid ischaemic complications. If Pcom occlusion is needed, exact surgical 286 
clip ligation rather than endovascular occlusion of a longer artery segment is probably safer 287 
strategy to keep perforators intact. Small superior hypophyseal artery (SHA) divisions are 288 
relatively safe to sacrifice in a unilateral procedure,26 and have no major role in our 289 
occlusion strategy planning. Distally, perfusion of the AChA has to be maintained if 290 
trapping is planned. We achieved an aneurysm occlusion rate of 83% (n=10) in ICAsup 291 
aneurysms of which the majority were treated with PAO (n=6). Due to flow pattern 292 
disruption, the postoperative, intra-aneurysmal residual flow seemed to be weak enough to 293 
ultimately lead to total thrombosis in most cases.  294 
 295 
Complex ICAbif aneurysms turned out to be the most heterogenous group in our series. For 296 
these aneurysms no general rule of occlusion strategy can be given. For proximal occlusion, 297 
one has to consider the same principles as with ICAsup aneurysms. It is essential to protect 298 
the AChA and lenticulostriatal perforators, which may be embedded in the aneurysm. 299 
Concerning the aneurysm outflows at main trunks, perfusion through the Acom may allow 300 
the occlusion of the ipsilateral A1, but the origin of artery of Heubner should be protected. 301 
Intraluminal aneurysm thrombosis may change the regional flow circumstances and lead to 302 
substantial perfusion through external carotid artery (ECA) collaterals. In our series, the 303 
aneurysm trapping was possible in two cases. If trapping is not possible, PAO and flow 304 
reversal may be a sufficient strategy to trigger aneurysm thrombosis, or change the flow 305 
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patterns into a more benign one. In aneurysms having multiple outflow branches along the 306 
intradural ICA, remodeling and compartmentalization of perfusion with the help of 307 
revascularization is a demanding strategy, and it highly depends on the aneurysm 308 
morphology. Flow disruption, rather than aneurysm isolation, is often an adequate 309 
treatment goal in bilateral ICAbif aneurysms, and is a tradeoff to avoid surgical 310 
complications. Disruption may be achieved with partial aneurysm occlusion, or with 311 
aneurysm inflow reduction. We do not routinely use electrophysiologic neuromonitoring, 312 
but even awake procedures27 may give extra control for the outcome when dealing with the 313 
most critical lesions. 314 
 315 
Bypass patency 316 
The cumulative bypass patency rate at the latest follow-up was 68% (n=30). This is 317 
relatively low when compared to previous studies showing patency rates from 73-77% 318 
(saphenous vein graft [SVG], ELANA) up to 98% (arterial pedicle).8,9,13,21,28–31 However, 319 
clinically relevant strokes were rare in our series. 320 
 321 
As observed previously by others28,29, majority of the bypass occlusions (n=9, 64%; all 322 
SVGs) occurred during the first postoperative week. Only some (n=6, 43%) of the early 323 
bypass occlusions resulted in ischaemic complications. This would indicate that despite the 324 
negative preoperative BTO, there must have been substantial collateral flow.  325 
 326 
The long-term patency rate has been reported to be up to 99% for arterial pedicles and 327 
SVGs.28 In our series, four bypasses (9%; SVGs) occluded as collateral perfusion had 328 
developed and bypass flow became unnecessary. Categorically, long-term bypass 329 
occlusions do not usually result in new ischaemic complications.29,31 330 
 331 
Ischaemic complications 332 
One-third (n=13) of the patients in our series had symptomatic ischaemic complications. 333 
The higher occurrence rate of ischaemic complications with intradural aneurysm cases 334 
(50%) when compared to ICAcav subgroup (37%) was likely related to the presence of 335 
branching arteries. In previous reports, the rate of ischaemic complications were reported 336 
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between 0-13%, but patient selection and reporting vary.6,8,13,20 Only one full hemispheric 337 
infarction was diagnosed after early bypass occlusion. In all other cases, the lesions were 338 
more limited regardless of the bypass status, and were mostly thromboembolic or local 339 
watershed-type of infarctions. 340 
 341 
Ischaemic lesions do not automatically mean poor prognosis. In our series, six symptomatic 342 
patients (46%) did not show functional decline during long-term follow-up. Only four out 343 
of the 13 patients (30%) with ischaemic lesions ended up with poor mRS score.  344 
 345 
Hemorrhagic complications 346 
Extra-axial hemorrhagic complications requiring surgical removal were diagnosed only 347 
infrequently (n=3, 7%) as seen in previous studies (4-10%)8,9,13. We did see small 348 
contusions/hemorrhagic complications in seven patients (18%). These were associated with 349 
the ELANA technique, which required longer surgery, static retraction32 and frequent 350 
heparinization. Currently, we prefer conventional bypass techniques with more superficial 351 
anastomoses which require less brain retraction and manipulation. At present, we use 352 
heparinized solution only locally for graft and recipient irrigation. 353 
 354 
Cranial nerve dysfunctions 355 
There are only a few reports focusing on CND improvement in patients treated with bypass 356 
surgery for ICA aneurysms. In our series, the preoperative vision deficits or 357 
ophthalmoplegia were common presenting symptoms (n=29, 74%) and only 45% of these 358 
patients (n=13) experienced improvement. Motor nerves of the extraocular muscles (CN 359 
III, IV and VI) showed low to moderate improvement rates during the follow-up (20-50%), 360 
whereas vision disturbance (CN II) improved only seldom (22%). Several other studies 361 
have reported  improvement rates of 30-85%.6,8,13 362 
 363 
Outcome 364 
When treating complex aneurysms with bypass procedures, the rate of good functional 365 
outcome has been reported to vary between 79-100%.8,9,13,21 We saw good functional 366 
outcome (mRS ≤2) in 74% of our patients at the latest follow-up (mean of four years). 367 
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Patient selection strongly affects these results so direct comparison between the different 368 
series is not possible. Many patients experience postoperative functional decline, but most 369 
of them seem to recover to their initial functional status later on. Patients with poor 370 
preoperative mRS score are unlikely to achieve independency again, which affects the 371 
overall outcome. Major ischaemic complications carry the highest risk for functional 372 
decline, but at least in our series these were infrequent. The case fatality rate in our series 373 
was 3% (n=1) which is similar to some previous reports (0-8%)9,13,21. 374 
 375 
Future role of bypass in ICA aneurysms 376 
Flow diverters have lately changed the treatment of complex ICA aneurysms, especially for 377 
the cavernous segment. It has been estimated that up to 90% of the ICA aneurysms are 378 
treatable with flow diverters.33 However, the likelihood of aneurysm occlusion is reported 379 
to be lower in cases of higher complexity and distal location.34,35 Thromboembolic events36 380 
or ruptures are known complications of flow diverters, and these may occur also late after 381 
the treatment. The need for dual antiplatelet therapy makes flow diverters difficult to 382 
combine with bypass surgery, and special devices for endovascular ICA bifurcation 383 
reconstruction are currently lacking. In our practice, during the last five years, we have 384 
nearly stopped bypass surgery for ICAcav aneurysms. For the more distal segments, bypass 385 
still remains as one of the treatment options. Revascularization offers an extra dimension of 386 
flexibility to attack the target aneurysm in cases where flow diverters are considered 387 
unsuitable, or they fail. At present, flow diversion and conventional, more superficial 388 
bypasses cover our need when treating complex ICA aneurysms. 389 
 390 
Conclusions 391 
Bypass surgery of complex ICA aneurysms is a feasible treatment method. The treatment 392 
strategy depends on the segmental location of the aneurysm. Major complications leading 393 
to long-term functional decline are rare. Preoperative cranial nerve dysfunctions recover 394 
only in a minority of the patients. Lately, flow diverters have taken over in many complex 395 
ICA aneurysms, but there is still need for bypasses in some special cases. The art of bypass 396 
treatment should be maintained in dedicated neurovascular centers. 397 
 398 
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 531 
Figure legends 532 
Figure 1. Illustration of the three aneurysm subgroups (n). ACA = anterior cerebral artery; 533 
AChA = anterior choroidal artery; ACP = anterior clinoid process; ICAbif = bifurcation of 534 
internal carotid artery; ICAcav = cavernous segment of internal carotid artery; ICAsup = 535 
supraclinoid segment of internal carotid artery; MCAbif = bifurcation of middle cerebral 536 
artery; OphtA = ophthalmic artery; Pcom = posterior communicating artery. 537 
 538 
Figure 2. A: Preoperative antero-posterior DSA image of ICAcav aneurysm [case no. 5] B: 539 
Preoperative antero-posterior DSA image of previously treated ICAsup aneurysm [case no. 540 
28] C: Preoperative antero-posterior 3D-CTA image of ICAbif aneurysm [case no. 36]. A1 541 
= A1 segment of anterior cerebral artery; ICAbif = bifurcation of internal carotid artery; 542 
M1 = M1 segment of middle cerebral artery; Pcom = posterior communicating artery. 543 
 544 
Figure 3. Distribution of the modified Rankin Scale score among the 39 patients. 545 
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Table 1 Characteristics of the patients (n).  
 
n (%) 
No. of patients 39 
No. of treated aneurysms 41 
Sex Female 21 (54%) 
Male 18 (46%) 
Age at surgery [yrs]; 
mean (range) 
50 (range 18-74) 
Preoperative modified 
Rankin Scale score 
0 – 2; independent 31 (79%) 
3 – 5; dependent 8 (21%) 
Main presenting symptom Mass effect (e.g. CND) 26 (67%) 
Incidental / co-incidental 5 (13%) 
Ischaemia 3 (8%) 
Headache 2 (5%) 
Previous SAH 2 (5%) 
Epistaxis (ruptured aneurysm) 1 (3%) 
Aneurysm ICA cavernous 23 / 41 (56%) 
 
ICA supraclinoid 12 / 41 (29%) 
 
ICA bifurcation 6 / 41 (15%) 
 Giant aneurysm (≥ 25 mm) 26 / 41  (63%) 
 
Multiple aneurysms 12 / 39 (31%) 
 → Bilateral ICA aneurysms 2 / 39 (5%) 
Previous treatment For the ICA aneurysm 10 / 39 (26%) 
 
For other aneurysm 3 / 39 (8%) 
 
CND = cranial nerve dysfunction; SAH = subarachnoid hemorrhage. 
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Table 2 ICAcav aneurysms treated with bypass surgery. 
 
No Gender; 
age 
Preop. 
/ late 
mRS 
CND Side; size (mm); 
morphology 
Calcif. / 
thromb. 
Multiple 
aneurysms 
Previous 
treatment 
Bypass type Anastomosis Obliteration Aneurysm 
filling postop. / 
late 
Bypass 
occluded 
Postop. 
radiologic 
ischaemia / 
contusions 
1 M; 42 1/1 III, V, VI Left; 32; f - / - + Other STA – MCA distal Conv. Prox./endo. - - - 
2 F; 45 1/1 II, III, V Left; 17; s - / + + + / Other ECA – SVG – ICAbif ELANA Proximal Slight / - - - / + 
3 F; 39 1/0 VI Left; 23; s - / - + - ECA – SVG – ICAid ELANA Proximal Slight / - < 7 days + / - 
4 M; 18 3/3 VI Left; 27; f + / + + - ECA – SVG – ICAid ELANA Proximal - - - 
 
bilateral   Right; 37; f + / +   ECA – SVG – ICAid ELANA Proximal Slight / Slight - - 
5 * F; 72 1/2 III-VI Left; 30; s  + / - - - STA – MCA distal Conv. Proximal + / - Intraop. - 
 reoperation       STA – SVG – M2 Conv. + Distal  < 7 days + / - 
6 M; 64 2/2 II, III, VI Right; 25; s + / + - - STA – MCA distal, x2 Conv. Distal + / - - - 
 
reoperation       STA – SVG – M2 Conv. + Proximal  - - 
7 F; 70 1/0 - Right; 32; s + / + + - STA – MCA distal, x2 Conv. Prox./endo. - - - 
8 M; 57 1/5 - Right; 30; traum. - / + - + ECA – SVG – ICAid ELANA Proximal - Follow-up - / + 
9 F; 45 1/1 VI Left; 32; s - / - - - ECA – SVG – ICAid ELANA Proximal - Follow-up - 
10 F; 56 1/1 VI Right; 28; s - / + - - ECA – SVG – ICAbif ELANA Proximal - < 7 days + / - 
11 M; 51 1/1 III, IV, VI Left; 22; s - / + - - ECA – SVG – ICAid ELANA Proximal - - - 
12 F; 55 1/0 - Right; 23; f - / - - - STA – M2 Conv. Prox./endo. Slight / - - - 
13 F; 44 1/0 III Right; 25; s - / + - + CCA – SVG – MCA distal Conv. Prox./endo. - Follow-up - 
14 F; 53 1/1 VI Left; 16; s + / + - - ECA – SVG – ICAid ELANA Trapping - - - / + 
15 F; 46 1/1 VI Right; 28; s - / - - - ECA – SVG – ICAid ELANA Proximal - - + / - 
16 F; 65 1/0 VI Left; 35; s - / - - - STA – MC  distal Conv. Prox./endo. - - + / - 
17 M; 54 1/1 VI Left; 17; s - / - - - ECA – SVG – ICAbif ELANA Proximal - < 7 days + / + 
18 M; 71 1/6 II Left; 23; s - / + - - ECA – SVG – ICAbif ELANA Prox. + endo. Slight / - < 7 days + / - 
19 M; 24 1/0 VI Right; 32; s + / + - - STA – MCA distal Conv. Distal - - - 
20 F; 62 3/3 V, VI Right; 25; s + / - - + ECA – SVG – MCA distal Conv. Crutchfield + / + < 7 days - 
21 F; 59 1/2 III Right; 16; s - / + + - ECA – SVG – ICAid ELANA Proximal Slight / - < 7 days + / + 
22 F; 58 1/1 III Right; 16; s - / + + - ECA – SVG – ICAid ELANA Proximal - Follow-up - 
 
*Later endovascular proximal occlusion obliterated the aneurysm. CND = cranial nerve dysfunction; ELANA = Excimer Laser-Assisted Non-occlusive Anastomosis; endo. = endovascular occlusion; f = 
fusiform; ICAbif = bifurcation of internal carotid artery; ICAid = intradural internal carotid artery; mRS = modified Ranking Scale; s = saccular; STA = superficial temporal artery; SVG = saphenous 
vein graft; traum. = traumatic. 
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Table 3 ICAsup aneurysms treated with bypass surgery. 
 
 Gender; 
age 
Preop.  
/ late 
mRS 
CND Side; size 
(mm); 
morphology 
Calcif. / 
thromb. 
Multiple 
aneurysms 
Previous 
treatment 
Bypass type Anastomosis Obliteration Aneurysm 
filling  postop. / 
late 
Bypass 
occluded 
Postop. radiologic 
ischaemia / 
contusions 
23 * F; 68 2/3 II Left; 32; f + / + - + STA – MCA distal Conv. Pcom/endo. Slight / - - + / - 
24 M; 56 5/5 III Left; 79; s + / + + - STA – MCA distal Conv. Proximal Slight / - - - 
25 † M; 55 0/1 - Right; 9; f - / - - - ECA – SVG – M2 Conv. Prox./endo. Slight / Foreign - + / - 
26 * F; 61 1/2 III Left; 25; f + / + + + STA – MCA distal Conv. Pcom/endo. - - + / - 
27 F; 47 4/3 - Right; 15; s - / - + Other ECA – SVG – M1 ELANA Proximal Slight / - - - / + 
28 M; 74 4/4 - Left; 30; s + / + + + / Other STA – SVG – M2 Conv. Proximal Slight / - - - 
29 F; 30 0/0 - Right; 17; f - / - - - STA – MCA distal Conv. Prox./endo. Slight / Slight - - 
30 F; 52 1/1 V Left; 40; s + / - - - ECA – SVG – M2 Conv. Trapping - - + / + 
31 F; 29 1/1 II Left; 19; s - / - - - STA – M2 Conv. Clipping - - + / - 
32 M; 25 1/1 II Left; 18; f - / - - + thyroid A – SVG – M2 ELANA None + / - Intraop. - 
 
reoperation       ECA – SVG – M2 Conv. Proximal  Follow-up - 
33 M; 24 1/2 VI Left; 30; f + / + - - ECA – SVG – MCA 
distal 
Conv. Proximal Slight / - - + / - 
34 M; 53 5/2 - Left; 2; s - / - - + STA – MCA distal Conv. Prox./endo. - - - 
 
*Remaining retrograde filling through the Pcom was occluded with endovascular means. †The ELANA arteriotomy failed and bypass was converted to a conventional type. CND = cranial nerve 
dysfunction; endo. = endovascular occlusion; f = fusiform; mRS = modified Ranking Scale; s = saccular; STA = superficial temporal artery; SVG = saphenous vein graft. 
. 
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Table 4 ICAbif aneurysms treated with bypass surgery. 
 
 Gender; 
age 
Preop. 
/ late 
mRS 
CND Side; size 
(mm); 
morphology 
Calcif. / 
thromb. 
Multiple 
aneurysms 
Previous 
treatment 
Bypass type Anastomosis Obliteration Aneurysm 
filling postop. / 
late 
Bypass 
occluded 
Postop. radiologic 
ischaemia / 
contusions 
35 * F; 65 1/1 II Right; 38; f - / - - - ECA – RAG – M2; STA – M3 Conv. Remodeling Small residual - + / - 
36 M; 18 3/3 - Right; 25; f - / - - - STA – MCA distal, x2 Conv. Trapping - - + / - 
37 M; 14 4/2 - Right; 70; s + / + - - STA – MCA distal, x2 Conv. Trapping - - - 
38 † F; 57 1/4 II Left; 50; s + / + - + STA – MCA distal Conv. Proximal - - + / - 
39 ‡ M; 50 1/2 II Right; 30; f + / + + - ECA – SVG – MCA distal Conv. Crutchfield Slight / Slight - - 
 bilateral   Left; 30; f + / +   STA – SVG – MCA distal Conv. Crutchfield + / + - - 
 
*Aneurysm was remodeled with clips and the bypasses provided perfusion to isolated ACA and MCA regions. †Previous unsuccessful treatment with a middle meningeal artery – MCA -bypass in another 
department. ‡The left-sided Crutchfield apparatus was purposefully left slightly open to allow diminished arterial flow to the aneurysm and periphery. CND = cranial nerve dysfunction; f = fusiform; 
mRS = modified Ranking Scale; RAG = radial artery graft; s = saccular; STA = superficial temporal artery; SVG = saphenous vein graft.  
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Table 5 The outcome scores on the modified Rankin Scale (n). 
 mRS score 
  0-2 3-5 (6) 
ICAcav (22)   
Preoperative 20 2 
Latest 18 3 (1) 
ICAsup (12)   
Preoperative 8 4 
Latest 8 4 
ICAbif (5)   
Preoperative 3 2 
Latest 3 2 
ICA aneurysm treated before (10)   
Preoperative 7 3 
Latest 6 4 
Postoperative ischaemia or contusions (21) 
Preoperative 19 2 
Latest 15 5 (1) 
Multiple aneurysms (12)   
Preoperative 8 4 
Latest 8 4 
Giant aneurysms (24)   
Preoperative 18 6 
Latest 16 8 
 
ICAbif = bifurcation of internal carotid artery; ICAcav = cavernous segment of internal carotid artery; ICAsup = supraclinoid segment of internal carotid artery. 
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Abbreviations 1 
A1, A1 segment of anterior cerebral artery; ACA, anterior cerebral artery; AChA, anterior 2 
choroidal artery; Acom, anterior communicating artery; ASA, asetylsalicylic acid; BTO, 3 
balloon test occlusion; CN, cranial nerve; CND, cranial nerve dysfunction; CT, computed 4 
tomography; CTA, computed tomography angiography; DSA, digital subtraction 5 
angiography; ECA, external carotid artery; EC-IC, extracranial-intracranial; ELANA, 6 
Excimer Laser-Assisted Non-occlusive Anastomosis; HUS, Helsinki University Hospital; 7 
ICA, internal carotid artery; ICAbif, bifurcation of internal carotid artery; ICAcav,  8 
cavernous segment of internal carotid artery; ICAsup, supraclinoid segment of internal 9 
carotid artery; LMWH, low-molecular-weight heparin; M1, M1 segment of middle cerebral 10 
artery; MCA, middle cerebral artery; MRI, magnetic resonance imaging; mRS, modified 11 
Rankin Scale; OphtA, ophthalmic artery; PACS, Picture Archiving and Communicating 12 
System; PAO, parent artery occlusion; PCA, posterior cerebral artery; Pcom, posterior 13 
communicating artery; RAG, radial artery graft; SAH, subarachnoid hemorrhage; SHA, 14 
superior hypophyseal artery; SVG, saphenous vein graft. 15 
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